Skip to main content

We try to speak plainly: what belongs on the open web and what is still bench work are spelled out on Research status. Good-faith corrections and sharp questions help us keep that line honest. If you need evaluation, licensing, a prototype, or an NDA conversation, start with Partners or Contact.

← Back to Hub

Contact

Phyllux landscape banner—teal and gold biomimetic field
Site banner art—contact routes below.

Contact — all email goes to the address below (use a clear subject: Phyllux commercial inquiry, Phyllux press inquiry, Phyllux security report, etc.):

Commercial threads still start from Partners. Strategic acquisition of the phyllux.io R&D package: read Strategic acquisition and the acquisition brief (PDF), then use the same email with subject Phyllux strategic acquisition inquiry. For what we will and will not say in public, see Research status and PhiKey.

If a dense research site is new to you, skim Research status first—it separates what we show from what still needs a bench or a contract. Same north star as everywhere else: flourishing you can trust—honest research, local-first craft where it fits.

Fiction tooling: Novelmate Studio uses novelmatestudio.com for public pricing and product pages. Use this Phyllux inbox for Phyllux threads; if your note is about Novelmate, say so in the subject so it can route cleanly.

If you are writing a serious commercial note, say who you are, the use case, a rough budget band, timeline, and whether you want evaluation, license, acquisition, investment, or a prototype talk. Hold confidential implementation detail until there is an NDA. For security reports, email phibronotchi@gmail.com with subject Phyllux security report (put exploit detail in the body, not the subject).